J
J. Baker
Researcher at University of Sydney
Publications - 6
Citations - 5771
J. Baker is an academic researcher from University of Sydney. The author has contributed to research in topics: Pravastatin & Framingham Risk Score. The author has an hindex of 5, co-authored 6 publications receiving 5676 citations.
Papers
More filters
Journal ArticleDOI
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
Andrew Tonkin,P. Alyward,David Colquhoun,Paul Glasziou,P. Harris,D. Hunt,Anthony C Keech,Stephen MacMahon,P. Magnus,D. Newel,P. Nestel,N. Sharpe,J. Shaw,R. J. Simes,P. Thompson,Alexis A. Thompson,Malcolm J. West,H. White,S. Simes,Wendy Hague,Sue Caleo,Jane Hall,Andrew J. Martin,S. Mulray,Philip J. Barter,Lawrence J. Beilin,Rory Collins,John J McNeil,Petra Meier,H. Willimott,D. Smithers,P. Wallace,J. Baker,M. Hobbs,David R. Sullivan,N. Anderson,Graeme J. Hankey,John D.G. Watson,M. Arulchelvam,S. Chup,John Daly,J. Hanna,A. Leach,M. Lee,J. Loughhead,H. Lundie-Jenkin,J. Morrison,S. Netting,A. Nguyen,H. Pater,R. Philip,G. Pinna,D. Rattos,S. Ryerson,V. Sazhin,Richard Walsh,A. Claque,M. Mackie,Julie Jane Yallop,K. Boss,M. Shepard,J. Leach,M. Gandy,J. Joughin,J. Seabrook,R. Abraham,J. Allen,F. Bates,I. Beinart,E. Breed,D. Brown,N. Bunyan,D. Calvert,T. Campbell,D. Condon-Paoloni,B. Conway,Lucy A. Coupland,J. Crowe,N. Cunio,B. Cuthbert,N. Cuthbert,S. D'Arcy,Patricia M. Davidson,B. Dwyer,J. England,C. Friend,Greg Fulcher,S. Grant,K. Hellestrand,M. Kava,Leonard Kritharides,D. McGill,H. McKee,Allan J. McLean,M. Neaverson,G. Nelson,M. O'Neill,C. Onuma,F. O'Reilly +98 more
TL;DR: Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespecified cardiovascular events in patients with a history of myocardial infarction or unstable angina who had a broad range of initial cholesterol levels.
Journal ArticleDOI
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
Anthony C Keech,David Colquhoun,James D. Best,Adrienne Kirby,R. John Simes,David M. Hunt,Wendy Hague,Elaine Beller,Manjula Arulchelvam,J. Baker,Andrew Tonkin +10 more
TL;DR: Cholesterol-lowering treatment with pravastatin therapy prevents cardiovascular events, including stroke, in patients with diabetes or IFG and established CHD and the absolute benefits of statin therapy in these patients were confirmed.
Journal Article
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (field study): a prespecified analysis of a randomised controlled trial
Kushwin Rajamani,Peter G. Colman,Liping Li,James D. Best,Merryn Voysey,Michael C d'Emden,Markku Laakso,J. Baker,Anthony C Keech,Investigators Fields. +9 more
TL;DR: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study as mentioned in this paper assessed the effect of fenofibrates on amputation events in a large cohort of patients with type 2 diabetes.
Journal ArticleDOI
Pravastatin reduces total mortality in patients with coronary heart disease and average cholesterol levels: relationship of baseline cholesterol and treatment effects in the LIPID trial
R. J. Simes,J. Baker,Stephen MacMahon,Wendy Hague,David Colquhoun,Malcolm J. West,M. Arulchelvam,Jonathan E. Shaw,Andrew Tonkin +8 more
Journal ArticleDOI
The incidence and notification of measles in australia
TL;DR: It is estimated that only 5 per cent of cases are notified in New South Wales, one of only 2 States which require notification, and the reasons for this, its significance and a possible remedy are discussed.